Doximity financials
$26.52+1.22%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Mar 31 | FY25 Mar 31 | FY24 Mar 31 | FY23 Mar 31 | FY22 Mar 31 |
|---|---|---|---|---|---|
| Revenue | $644.9M | $570.4M | $475.4M | $419.1M | $343.5M |
| Gross profit | $574.5M | $514.5M | $424.8M | $365.6M | $303.8M |
| Gross margin | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% |
| Operating income | $214.9M | $227.8M | $163.9M | $125.1M | $113.5M |
| Net income | $196.1M | $223.2M | $147.6M | $112.8M | $133.3M |
| Net margin | 30.4% | 39.1% | 31.0% | 26.9% | 38.8% |
| Diluted EPS | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 |
| EBITDA | $242.8M | $250.7M | $190.9M | $144.2M | $128.3M |
| Operating cash flow | $326.5M | $273.3M | $184.1M | $179.6M | $126.6M |
| Free cash flow | $326.5M | $273.3M | $183.9M | $177.9M | $124.7M |
| Diluted shares | 199.0M | 201.2M | 205.7M | 213.4M | 191.0M |
Balance sheet
| Period end | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $219.2M | $209.6M | $96.8M | $158.0M | $112.8M |
| Short-term investments | $529.4M | $706.0M | $666.1M | $683.0M | $685.3M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $1.12B | $1.26B | $1.08B | $1.14B | $991.4M |
| Total liabilities | $172.8M | $181.7M | $178.0M | $170.8M | $112.8M |
| Shareholders' equity | $950.8M | $1.08B | $901.4M | $966.1M | $878.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology